Change over period
From:
To:
Zoom:
- 3M
- 6M
- YTD
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
Creative Medical Technology Holdings Inc
NASDAQ CELZ
Data sourced from
and
and
Download Data
Creative Medical Technology Holdings Inc Enterprise Value (EV) on June 03, 2024
Creative Medical Technology Holdings Inc Enterprise Value (EV) is NA on June 03, 2024, a NA change year over year. Enterprise Value is a measure of a company's total value, including both its equity and debt. It represents the theoretical takeover price of a company and is often used in valuation methods. Enterprise value is calculated as the sum of a company's market capitalization, total debt, and subtracting its cash and short-term investments.
-
Creative Medical Technology Holdings Inc 52-week high Enterprise Value (EV) is NA on June 03, 2024, which is NA below the current Enterprise Value (EV).
-
Creative Medical Technology Holdings Inc 52-week low Enterprise Value (EV) is NA on June 03, 2024, which is NA below the current Enterprise Value (EV).
-
Creative Medical Technology Holdings Inc average Enterprise Value (EV) for the last 52 weeks is NA.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: CELZ
| CEO | Mr. Timothy Warbington |
| IPO Date | Nov. 6, 2015 |
| Location | United States |
| Headquarters | 211 East Osborn Road, Phoenix, AZ, United States, 85012 |
| Employees | 4 |
| Sector | Healthcare |
| Industry | Biotechnology |
Description
Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Key trends
StockViz Staff
September 19, 2024
Any question? Send us an email